Home
About Us
Products
R & D
CSR
Global
Payments
Knowledge Desk
ADR Reporting
Medical Conference
Contact Us
Updates
ARISTO
has registered highest growth rate (14.55%) among top 12 pharmaceutical companies in India (Source-IMS MAT April 2017)
ARISTO
is ranked No. 3 in its covered market (Source-IMS MAT April 2017)
ARISTO
continues to be among the top 10 companies of India as per SMSRC prescription audit
ARISTO
has introduced India’s 1st ready-to-use, multi-dose probiotic formulation ‘Darolac Syrup’ in association with Royal Holloway University of London
ARISTO
has launched ready-to-drink, WHO recommended ORS formula ‘Olyte ORS’.
ARISTO
has entered anticoagulant segment with the launch of ‘Fondum’ PFS
Featured
ARISTO
has entered anticoagulant segment with the launch of ‘Fondum’ PFS
Share
Posted:
June 19, 2017 at 9:16 am / by
@Aristo
/
comments (0)
tags:
error:
Content is protected !!